Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacologic Interventions for CVD in OSA
NCT01637623Phase 2Completed
- Sponsor
- University of Wisconsin–Madison
- Start
- Jun 2012
- Primary completion
- Jun 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of losartan, allopurinol in hypertension (HTN), cardiovascular disease (CVD), sponsored by University of Wisconsin–Madison. Started Jun 2012; status: completed.
02
Drugs
losartanallopurinol
03
Conditions
hypertension (HTN)cardiovascular disease (CVD)
Beyond the preview
Go deeper on NCT01637623.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01637623.